(Tetrahydrofuran-3-yl)methanamine hydrochloride

Catalog No.: 
ACZIWC859
CAS No.: 
184950-35-4
Molecular Formula: 
C5H12ClNO
Molecular Weight: 
137.61
(Tetrahydrofuran-3-yl)methanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$51.00In stockInquiry
100g97%$200.00InquiryInquiry
500g97%$990.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Tetrahydrofuran-3-yl)methanamine hydrochloride
IUPAC Name(tetrahydrofuran-3-yl)methanamine hydrochloride
MDL No.MFCD08448154
Molecular FormulaC5H12ClNO
Molecular Weight137.61
SMILESNCC1COCC1.[H]Cl
InChI KeyLZHYUVOFRJAJKS-UHFFFAOYSA-N
Synonym184950-35-4 | (Tetrahydrofuran-3-yl)methanamine hydrochloride | oxolan-3-ylmethanamine hydrochloride | (TETRAHYDROFURAN-3-YL)METHANAMINE HCL | oxolan-3-ylmethanamine;hydrochloride | C-(Tetrahydro-furan-3-yl)-methylamine hydrochloride | (Tetrahydrofuran-3-yl)methanami
CAS No.184950-35-4
PubChem CID17750392

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACZIWC859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZBHN968 route compound structure diagram
    ACZBHN96814631-44-8In Stock
  2. Then
  3. ACZIWC859 route product structure diagram
    ACZIWC859184950-35-4In Stock
Inquiry

2. ACZIWC859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZIWC859 route product structure diagram
    ACZIWC859184950-35-4In Stock
Inquiry

3. ACZIWC859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZIWC859 route product structure diagram
    ACZIWC859184950-35-4In Stock
Inquiry

Comments (0)